Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christof von Kalle

Showing results (1-10 of 260) with videos related to

Pageof 26
Sort By:
MMW Fortschritte Der Medizin|May 28, 2024
Christof von Kalle
MMW Fortschritte Der Medizin|June 4, 2021
Christof von Kalle
Onkologie|January 31, 2012
Recent developments and future perspectives of personalized oncologyCarsten Grüllich, Christof von Kalle
Acta Haematologica|October 30, 2003
Gene therapy targeting hematopoietic cells: better not leave it to chanceChristopher Baum, Christof von Kalle
International Journal of Cancer|June 22, 2017
Special Section: From Genes to Bedside and BackPeter Lichter, Christof von Kalle
Human Gene Therapy|June 21, 2014
Vector integration and tumorigenesisChristof von Kalle, Annette Deichmann, Manfred Schmidt
Future Microbiology|November 16, 2010
Retroviral vectors for gene therapyPatrick Maier, Christof von Kalle, Stephanie Laufs
Nature Biotechnology|February 7, 2015
Mapping the precision of genome editingRichard Gabriel, Christof von Kalle, Manfred Schmidt
Human Gene Therapy|September 28, 2017
Gene and Cell Therapy in GermanyChristof von Kalle, Boris Fehse, Hildegard Büning
Current Opinion in Immunology|September 18, 2012
Integration of retroviral vectorsRichard Gabriel, Manfred Schmidt, Christof von Kalle
Pageof 26

Showing results (1-10 of 260) with videos related to

Sort By:
Pageof 26
MMW Fortschritte Der Medizin|May 28, 2024
Christof von Kalle
MMW Fortschritte Der Medizin|June 4, 2021
Christof von Kalle
Onkologie|January 31, 2012
Recent developments and future perspectives of personalized oncologyCarsten Grüllich, Christof von Kalle
Acta Haematologica|October 30, 2003
Gene therapy targeting hematopoietic cells: better not leave it to chanceChristopher Baum, Christof von Kalle
International Journal of Cancer|June 22, 2017
Special Section: From Genes to Bedside and BackPeter Lichter, Christof von Kalle
Human Gene Therapy|June 21, 2014
Vector integration and tumorigenesisChristof von Kalle, Annette Deichmann, Manfred Schmidt
Future Microbiology|November 16, 2010
Retroviral vectors for gene therapyPatrick Maier, Christof von Kalle, Stephanie Laufs
Nature Biotechnology|February 7, 2015
Mapping the precision of genome editingRichard Gabriel, Christof von Kalle, Manfred Schmidt
Human Gene Therapy|September 28, 2017
Gene and Cell Therapy in GermanyChristof von Kalle, Boris Fehse, Hildegard Büning
Current Opinion in Immunology|September 18, 2012
Integration of retroviral vectorsRichard Gabriel, Manfred Schmidt, Christof von Kalle
Pageof 26